Document is current
Any future updates will be listed below
-
Authors
Martin-Morales, Raquel
Barbeito, Pablo
Sierra-Rodero, Belén
Jimenez, Lucia
Schrøder Holm, Maria
Grijalva-Bravo, Andrea
Cilleros-Rodríguez, Darío
Ebert, Lena K.
Cortabarría, Matilde
Pedersen, Lotte B.
Badano, Jose L.
Irigoín, Florencia
Schermer, Bernhard
Link, Wolfgang
Christensen, Søren T.
Garcia-Gonzalo, Francesc R. https://orcid.org/0000-0002-9152-2191
-
Funding
Funding for this research was provided by:
Agencia Nacional de Investigación e Innovación (ANII) and Programa para el Desarrollo de las Ciencias Básicas, Uruguay
European Union's Horizon 2020 Marie Sklodowska-Curie Innovative Training Networks (861329)
European Union's Horizon 2020 Marie Sklodowska-Curie Innovative Training Networks (861329)
Independent Research Fund Denmark (2032-00115B)
Independent Research Fund Denmark (3103-00177B)
Carlsberg Foundation (CF22-0670)
TheRaCil consortium funded by the European Union (101080717)
Novo Nordisk Foundation (NNF18SA0032928 and NNF22OC0080406)
Comisión Sectorial de Investigación Científica (CSIC), Universidad de la República, Uruguay
Deutsche Forschungsgemeinschaft (DFG; FOR5547; SCHE1562/12-1)
Ministerio de Ciencia e Innovación (PID2022-136654OB-I00)
Ministerio de Ciencia e Innovación (PID2023-149472NB-I00)
Købmand Niels Erik Munk Pedersen Fonden (2022-34)
Lundbeck Foundation (R436-2023-843)
- License Information
-
More Information
Article History
Received: 19 February 2026
Accepted: 21 August 2026
First Online: 1 September 2026
Declarations
Competing interests: W.L. is cofounder of Refoxy Pharmaceuticals GmbH, Cologne, Germany, and required by his institution to state so in his publications.
